An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a study.

H LeCaer,P Fournel,H Jullian,C Chouaid,J Letreut,P Thomas,D Paillotin,M Perol,C Gimenez,A Vergnenegre

Critical Reviews in Oncology/Hematology（2007）

引用 23|浏览13

暂无评分

摘要

The aim of this study was to determine the impact of patient selection based on age, comorbidity and performance status on the efficacy of platinum-free combination therapy on non-small-cell lung cancer after 65 years of age.

查看译文

关键词

Chemotherapy,Comorbidity,Elderly,Lung cancer,Phase II trial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要